Your browser doesn't support javascript.
loading
Long-term Outcome With Prolonged Use of Interferon-alpha Administered Intermittently for Metastatic Renal Cell Carcinoma: A Phase II Study.
Kankuri-Tammilehto, Minna; Perasto, Laura; Pyrhonen, Seppo; Salminen, Eeva.
Afiliação
  • Kankuri-Tammilehto M; Department of Oncology and Radiotherapy, Turku University Hospital, Turku, Finland; mikanku@utu.fi.
  • Perasto L; Department of Clinical Genetics, Turku University Hospital, Turku, Finland.
  • Pyrhonen S; Institute of Biomedicine, University of Turku, Turku, Finland.
  • Salminen E; Institute of Clinical Medicine, Department of Biostatistics, University of Turku, Turku, Finland.
Anticancer Res ; 43(6): 2645-2657, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37247917
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Idioma: En Ano de publicação: 2023 Tipo de documento: Article